Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications

Rifaximin improves thrombocytopenia in patients with alcoholic cirrhosis in association with reduction of endotoxaemia

(2015) Georgios N. Kalambokis et al.   LIVER INTERNATIONAL

Rifaximin Improves Systemic Hemodynamics and Renal Function in Patients With Alcohol-Related Cirrhosis and Ascites

(2012) Georgios N. Kalambokis et al.   Clinical Gastroenterology and Hepatology

Prevention of acute kidney injury in a rodent model of cirrhosis following selective gut decontamination is associated with reduced renal TLR4 expression

(2012) Naina Shah et al.   JOURNAL OF HEPATOLOGY

Rifaximin reduces endotoxemia and improves liver function and disease severity in patients with decompensated cirrhosis

(2011) Georgios N. Kalambokis et al.   HEPATOLOGY

Detection of bacterial DNA in serum and ascitic fluid of asymptomatic outpatients with cirrhosis and non-neutrocytic ascites

(2011) Thomas Sersté et al.   LIVER INTERNATIONAL

Rifaximin Improves Psychometric Performance and Health-Related Quality of Life in Patients With Minimal Hepatic Encephalopathy (The RIME Trial)

(2010) Sandeep Singh Sidhu et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Infections in Patients With Cirrhosis Increase Mortality Four-Fold and Should Be Used in Determining Prognosis

(2010) Vasiliki Arvaniti et al.   GASTROENTEROLOGY

Rifaximin Improves Driving Simulator Performance in a Randomized Trial of Patients With Minimal Hepatic Encephalopathy

(2010) Jasmohan S. Bajaj et al.   GASTROENTEROLOGY

Bacterial DNA translocation is associated with systemic circulatory abnormalities and intrahepatic endothelial dysfunction in patients with cirrhosis

(2010) Pablo Bellot et al.   HEPATOLOGY

Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy

(2010) Ankur Gupta et al.   JOURNAL OF HEPATOLOGY

Association Between Small Intestinal Bacterial Overgrowth and Peripheral Bacterial DNA in Cirrhotic Patients

(2009) Dae Won Jun et al.   DIGESTIVE DISEASES AND SCIENCES

Nucleotide-binding oligomerization domain containing 2 (NOD2) variants are genetic risk factors for death and spontaneous bacterial peritonitis in liver cirrhosis

(2009) Beate Appenrodt et al.   HEPATOLOGY

Identification of bacterial DNA in neutrocytic and non-neutrocytic cirrhotic ascites by means of a multiplex polymerase chain reaction

(2009) Tony Bruns et al.   LIVER INTERNATIONAL

Bacterial DNA in patients with cirrhosis and noninfected ascites mimics the soluble immune response established in patients with spontaneous bacterial peritonitis

(2008) Rubén Francés et al.   HEPATOLOGY

Serum and ascitic fluid bacterial DNA: A new independent prognostic factor in noninfected patients with cirrhosis

(2008) Pedro Zapater et al.   HEPATOLOGY

Ciprofloxacin in primary prophylaxis of spontaneous bacterial peritonitis: A randomized, placebo-controlled study

(2008) Rubén Terg et al.   JOURNAL OF HEPATOLOGY

Presence of bacterial-DNA in cirrhosis identifies a subgroup of patients with marked inflammatory response not related to endotoxin

(2007) José M. González-Navajas et al.   JOURNAL OF HEPATOLOGY